Saturday, 17 October 2026European Markets

LUMIBIRD Stock Bullish By 9% So Far On Tuesday

Loading stream...

(vianews) - shares of lumibird (cac 40: lbird.pa) jumped 9.22% to €15.40 at 14:53 est on tuesday, following the last session's upward trend. cac 40 is rising 0.02% to €7,419.81, after three consecutive sessions in a row of gains. this seems, as yet, a somewhat positive trend exchanging session today.

about lumibird

lumibird sa designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. it operates in two segments, photonics and medical. the company offers solid-state and diode lasers, fiber lasers, fiber lasers/amplifiers and components, laser rangefinder and lidar wind doppler lidar, medical and ophthalmological equipment. its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. the company was incorporated in 1970 and is headquartered in lannion, france.

earnings per share

as for profitability, lumibird has a trailing twelve months eps of €0.45.

pe ratio

lumibird has a trailing twelve months price to earnings ratio of 34.22. meaning, the purchaser of the share is investing €34.22 for every euro of annual earnings.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, lumibird's stock is considered to be oversold (<=20).

volatility

lumibird's last week, last month's, and last quarter's current intraday variation average was 1.72%, 0.23%, and 1.73%.

lumibird's highest amplitude of average volatility was 1.72% (last week), 2.13% (last month), and 1.73% (last quarter).

more news about lumibird (lbird.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com